Literature DB >> 11242049

Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice.

E A Lindsay1, F Vitelli, H Su, M Morishima, T Huynh, T Pramparo, V Jurecic, G Ogunrinu, H F Sutherland, P J Scambler, A Bradley, A Baldini.   

Abstract

DiGeorge syndrome is characterized by cardiovascular, thymus and parathyroid defects and craniofacial anomalies, and is usually caused by a heterozygous deletion of chromosomal region 22q11.2 (del22q11) (ref. 1). A targeted, heterozygous deletion, named Df(16)1, encompassing around 1 megabase of the homologous region in mouse causes cardiovascular abnormalities characteristic of the human disease. Here we have used a combination of chromosome engineering and P1 artificial chromosome transgenesis to localize the haploinsufficient gene in the region, Tbx1. We show that Tbx1, a member of the T-box transcription factor family, is required for normal development of the pharyngeal arch arteries in a gene dosage-dependent manner. Deletion of one copy of Tbx1 affects the development of the fourth pharyngeal arch arteries, whereas homozygous mutation severely disrupts the pharyngeal arch artery system. Our data show that haploinsufficiency of Tbx1 is sufficient to generate at least one important component of the DiGeorge syndrome phenotype in mice, and demonstrate the suitability of the mouse for the genetic dissection of microdeletion syndromes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11242049     DOI: 10.1038/35065105

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  316 in total

1.  The septin CDCrel-1 is dispensable for normal development and neurotransmitter release.

Authors:  Xiao-Rong Peng; Zhengping Jia; Yu Zhang; Jerry Ware; William S Trimble
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

2.  A haplolethal locus uncovered by deletions in the mouse T complex.

Authors:  Victoria L Browning; Rebecca A Bergstrom; Sandra Daigle; John C Schimenti
Journal:  Genetics       Date:  2002-02       Impact factor: 4.562

Review 3.  Building a heart: implications for congenital heart disease.

Authors:  Deepak Srivastava
Journal:  J Nucl Cardiol       Date:  2003 Jan-Feb       Impact factor: 5.952

Review 4.  The genetics of congenital heart disease.

Authors:  Paul D Grossfeld
Journal:  J Nucl Cardiol       Date:  2003 Jan-Feb       Impact factor: 5.952

5.  Functional analysis of TBX5 missense mutations associated with Holt-Oram syndrome.

Authors:  Chun Fan; Mugen Liu; Qing Wang
Journal:  J Biol Chem       Date:  2002-12-23       Impact factor: 5.157

6.  Transcription factor TBX1 overexpression induces downregulation of proteins involved in retinoic acid metabolism: a comparative proteomic analysis.

Authors:  Marianna Caterino; Margherita Ruoppolo; Gabriella Fulcoli; Tuong Huynth; Stefania Orrù; Antonio Baldini; Francesco Salvatore
Journal:  J Proteome Res       Date:  2009-03       Impact factor: 4.466

7.  Enamel-free teeth: Tbx1 deletion affects amelogenesis in rodent incisors.

Authors:  Javier Catón; Hans-Ulrich Luder; Maria Zoupa; Matthew Bradman; Gilles Bluteau; Abigail S Tucker; Ophir Klein; Thimios A Mitsiadis
Journal:  Dev Biol       Date:  2009-02-20       Impact factor: 3.582

8.  mef2ca is required in cranial neural crest to effect Endothelin1 signaling in zebrafish.

Authors:  Craig T Miller; Mary E Swartz; Patricia A Khuu; Macie B Walker; Johann K Eberhart; Charles B Kimmel
Journal:  Dev Biol       Date:  2007-05-24       Impact factor: 3.582

9.  Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function.

Authors:  Marcus Conrad; Cemile Jakupoglu; Stéphanie G Moreno; Stefanie Lippl; Ana Banjac; Manuela Schneider; Heike Beck; Antonis K Hatzopoulos; Ursula Just; Fred Sinowatz; Wolfgang Schmahl; Kenneth R Chien; Wolfgang Wurst; Georg W Bornkamm; Markus Brielmeier
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

10.  Functional variants in TBX2 are associated with a syndromic cardiovascular and skeletal developmental disorder.

Authors:  Ning Liu; Kelly Schoch; Xi Luo; Loren D M Pena; Venkata Hemanjani Bhavana; Mary K Kukolich; Sarah Stringer; Zöe Powis; Kelly Radtke; Cameron Mroske; Kristen L Deak; Marie T McDonald; Allyn McConkie-Rosell; M Louise Markert; Peter G Kranz; Nicholas Stong; Anna C Need; David Bick; Michelle D Amaral; Elizabeth A Worthey; Shawn Levy; Michael F Wangler; Hugo J Bellen; Vandana Shashi; Shinya Yamamoto
Journal:  Hum Mol Genet       Date:  2018-07-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.